Has Daniel Perez Brisebois, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,295 in general payments to Daniel Perez Brisebois, MD across 28 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Daniel Perez Brisebois, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Daniel Perez Brisebois, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Daniel Perez Brisebois, MD

Nephrology · Ponce, PRNPI 1780746305

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.7% of the total across 28 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by AstraZeneca at 39.5% of the total. Reporting peaked in 2023 at $451 and has fallen 76.6% since, to $105 in 2025. That places this record below the midpoint for nephrology clinicians in PR, where the typical reported total is $1,755.

$1,295in general payments, 2019–2025

Across 28 payments — averaging $46.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$511
Nxstage Medical, Inc.$247
Fresenius USA Marketing, Inc.$154
Bayer$142
Medtronic$76
Mallinckrodt Hospital Products Inc.$60
plus $104 from 2 others

What the payments were for

Food & beverage$1,23996%
Education$564%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	19	$511
Nxstage Medical, Inc.	2	$247
Fresenius USA Marketing, Inc.	1	$154
Bayer	2	$142
Medtronic	1	$76
Mallinckrodt Hospital Products Inc.	1	$60
Travere Therapeutics, Inc.	1	$56
Amgen	1	$49

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

LIBERTY SELECT CYCLER$316
NXSTAGE SYSTEM ONE$316

How this compares

$1,295 in reported general payments places this provider in the 35th percentile of 161 nephrology providers in Puerto Rico.

See all nephrology providers in Puerto Rico →

Medicare billing

Part B allowed, 2024

$16,494

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Sevelamer Carbonate	281	$34,590
JanuviaSitagliptin Phosphate	43	$28,081
TradjentaLinagliptin	40	$23,547
Calcium Acetate	83	$8,396
Breo ElliptaFluticasone/Vilanterol	13	$5,363
Saxagliptin-Metformin ErSaxagliptin Hcl/Metformin Hcl	13	$2,314
SynthroidLevothyroxine Sodium	34	$1,915
Amlodipine Besylate	337	$1,636
Carvedilol	169	$1,359
HumalogInsulin Lispro	15	$1,352
Hydralazine Hcl	94	$1,351
Losartan Potassium	172	$1,264
Famotidine	142	$1,214
Terazosin Hcl	78	$1,150
LantusInsulin Glargine,hum.Rec.Anlog	14	$933

Paid to pharmacies, not to this prescriber.

Other nephrology in Ponce

See the full list for Puerto Rico →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →